Especially if it means an overnight stay at the hospital.
The TLX research report is saying supply constraints for Cu64-67, I would genuinely like to know what those are and how does that compare to SOC/ other approved products.
Many people are asking UBS about Clarity. Surely there is a reason for it. But UBS doesn’t think Clarity stacks up while FDA grants Cu64 FTD. Go figure!
CU6 - Media and Industry News, page-412
-
- There are more pages in this discussion • 219 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.76 |
Change
-0.070(1.02%) |
Mkt cap ! $2.164B | |||
| Open | High | Low | Value | Volume |
| $6.74 | $6.80 | $6.65 | $4.278M | 636.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1558 | $6.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.76 | 2321 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |